14.18
Precedente Chiudi:
$13.80
Aprire:
$13.87
Volume 24 ore:
156.34K
Relative Volume:
0.38
Capitalizzazione di mercato:
$559.63M
Reddito:
$771.65M
Utile/perdita netta:
$-120.49M
Rapporto P/E:
-4.4451
EPS:
-3.19
Flusso di cassa netto:
$-73.76M
1 W Prestazione:
+12.84%
1M Prestazione:
+28.05%
6M Prestazione:
-22.76%
1 anno Prestazione:
-8.94%
Orthofix Medical Inc Stock (OFIX) Company Profile
Nome
Orthofix Medical Inc
Settore
Industria
Telefono
214-937-2000
Indirizzo
3451 PLANO PARKWAY, LEWISVILLE, TX
Confronta OFIX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OFIX
Orthofix Medical Inc
|
14.17 | 511.06M | 771.65M | -120.49M | -73.76M | -3.19 |
![]()
ABT
Abbott Laboratories
|
129.28 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
102.74 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
377.48 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.92 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.69 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-22 | Iniziato | Canaccord Genuity | Buy |
2024-11-08 | Aggiornamento | Stifel | Hold → Buy |
2024-05-08 | Aggiornamento | ROTH MKM | Neutral → Buy |
2023-10-20 | Iniziato | ROTH MKM | Neutral |
2023-09-12 | Downgrade | BTIG Research | Buy → Neutral |
2023-09-12 | Downgrade | Stifel | Buy → Hold |
2023-07-19 | Ripresa | BTIG Research | Buy |
2022-03-04 | Aggiornamento | Stifel | Hold → Buy |
2020-10-20 | Iniziato | Stifel | Hold |
2019-10-29 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
2017-06-21 | Iniziato | BTIG Research | Buy |
2017-06-14 | Iniziato | Ladenburg Thalmann | Buy |
2017-05-23 | Iniziato | SunTrust | Buy |
2015-07-10 | Iniziato | Sidoti | Buy |
2013-05-09 | Downgrade | Mizuho | Buy → Neutral |
2013-01-08 | Reiterato | Mizuho | Buy |
2010-06-21 | Iniziato | Boenning & Scattergood | Outperform |
2010-03-09 | Reiterato | Jefferies & Co | Buy |
2010-02-18 | Aggiornamento | Susquehanna Financial | Neutral → Positive |
2010-01-22 | Iniziato | Jefferies & Co | Buy |
2009-11-03 | Aggiornamento | Wells Fargo | Underperform → Market Perform |
2009-07-31 | Reiterato | Jefferies & Co | Buy |
2009-07-31 | Aggiornamento | Thomas Weisel | Market Weight → Overweight |
2009-05-26 | Reiterato | Jefferies & Co | Buy |
2009-04-17 | Downgrade | Wachovia | Mkt Perform → Underperform |
2009-02-19 | Iniziato | Canaccord Adams | Buy |
2008-07-07 | Downgrade | Wachovia | Outperform → Mkt Perform |
Mostra tutto
Orthofix Medical Inc Borsa (OFIX) Ultime notizie
Orthofix Medical Inc. Matches Institutional Buying FilterTrade Signal Summary & Step-by-Step Swing Trade Plans - 선데이타임즈
Orthofix Beats Expectations for Q2 2025 - Orthopedics This Week
12 Best Medical Device Stocks to Buy According to Analysts - Insider Monkey
Orthofix Medical Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – OFIX - ACCESS Newswire
Cervical Total Disc Replacement Device Market to Grow at 20.9% - openPR.com
Orthofix Medical: Attractive Valuation Amid Insider Buying - AInvest
Orthofix Medical: Compelling Valuation Supported By Insider Purchases (OFIX) - Seeking Alpha
Orthofix anticipates full-year net sales of $808M–$816M while accelerating U.S. spine distributor transition - MSN
External Fixators Market to Surpass $1.48 Billion by 2033, - openPR.com
Orthofix Medical Inc. (NASDAQ:OFIX) Q2 2025 Earnings Call Transcript - Insider Monkey
Orthofix Q2 2025 net sales up 2.3% to USD 203.1 million - Medical Buyer
Orthofix Medical 2025 Q2 Earnings Losses Narrow by 59.1% - AInvest
Orthofix Reports Second Quarter 2025 Financial Results - BioSpace
Orthofix: Q2 Earnings Snapshot - New Haven Register
Orthofix Medical Inc (OFIX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... By GuruFocus - Investing.com Canada
Orthofix Medical Inc (OFIX) Q2 2025 Earnings Call Highlights: St - GuruFocus
Orthofix (OFIX) Q2 Revenue Rises 2% - The Motley Fool
Orthofix Q2 2025 slides: Positive free cash flow achieved amid strong U.S. growth - Investing.com
Earnings call transcript: Orthofix beats Q2 2025 forecasts, stock surges - Investing.com
Earnings call transcript: Orthofix beats Q2 2025 forecasts, stock surges By Investing.com - Investing.com India
Orthofix stock rises on Street-beating Q2 - MassDevice
Orthofix Q2 2025: Navigating Key Contradictions in Spine Transition, AccelStim Launch, and Pricing Strategy - AInvest
Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Orthofix Medical Q2 Financial Results: Loss and Revenue GrowthNews and Statistics - IndexBox
Medtech Orthofix Medical Q2's sales growth beat expectations - MarketScreener
Orthofix Reports Q2 2025 Financial Results and Growth - TipRanks
Orthofix Medical Inc. SEC 10-Q Report - TradingView
Orthofix Medical Inc. Reaches Critical Trendline SupportSwing Trading Entry Signals Suggest Opportunity Zone - metal.it
Is it the right time to buy Orthofix Medical Inc. stockFree Stock Market Real-Time Monitoring - Jammu Links News
What are the technical indicators suggesting about Orthofix Medical Inc.Achieve rapid portfolio appreciation today - Jammu Links News
Is Orthofix Medical Inc. stock overvalued or undervaluedSkyrocketing returns - Jammu Links News
What institutional investors are buying Orthofix Medical Inc. stockHigh-yield market plays - Jammu Links News
What is the dividend policy of Orthofix Medical Inc. stockStay informed with expert market forecasts - Jammu Links News
Orthofix Medical Inc. Stock Analysis and ForecastMarket-leading growth rates - Jammu Links News
How volatile is Orthofix Medical Inc. stock compared to the marketCapitalize on emerging investment opportunities - Jammu Links News
Is Orthofix Medical Inc. a growth stock or a value stockAccelerated wealth expansion - Jammu Links News
When is Orthofix Medical Inc. stock expected to show significant growthCapitalize on proven investment strategies - Jammu Links News
What are Orthofix Medical Inc. company’s key revenue driversFree Stock Movement Tracking - Jammu Links News
How does Orthofix Medical Inc. generate profit in a changing economyTurbocharged investment results - Jammu Links News
What analysts say about Orthofix Medical Inc. stockDiscover high-impact investment opportunities - Jammu Links News
What are analysts’ price targets for Orthofix Medical Inc. in the next 12 monthsMassive stock growth - Jammu Links News
Why is Orthofix Medical Inc. stock attracting strong analyst attentionHigh-performance stocks for savvy investors - Jammu Links News
Press Release: Orthofix to Report Second Quarter 2025 Financial Results - 富途牛牛
Published on: 2025-08-01 21:25:19 - metal.it
Orthofix Medical's High Institutional Ownership Indicates Market Sensitivity - AInvest
With 53% institutional ownership, Orthofix Medical Inc. (NASDAQ:OFIX) is a favorite amongst the big guns - Yahoo Finance
Is Orthofix Medical Inc. stock bottoming outReal Profit Trade Plan Suggestions Shared Widely - metal.it
Orthofix Medical Inc Azioni (OFIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Orthofix Medical Inc Azioni (OFIX) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
McPherron Aviva | Pres, Global Ops & Qual |
Jun 18 '25 |
Sale |
10.51 |
3,728 |
39,181 |
46,322 |
REINHARDT MAX | President, Global Spine |
Jun 11 '25 |
Sale |
11.64 |
1,643 |
19,125 |
27,481 |
Bazaar Alan Lee | Director |
Jun 04 '25 |
Buy |
10.92 |
2,250 |
24,570 |
30,983 |
Calafiore Massimo | President & CEO |
May 09 '25 |
Buy |
12.54 |
10,000 |
125,400 |
234,603 |
Bazaar Alan Lee | Director |
May 12 '25 |
Buy |
12.59 |
2,000 |
25,172 |
28,733 |
Bazaar Alan Lee | Director |
May 09 '25 |
Buy |
12.62 |
1,990 |
25,120 |
26,733 |
Engine Capital Management, LP | 10% Owner |
May 07 '25 |
Buy |
12.31 |
100,000 |
1,231,000 |
3,544,807 |
Cedron Jorge Andres | CLO |
Apr 16 '25 |
Sale |
13.31 |
3,816 |
50,791 |
42,500 |
Gillespie Geoffrey C | CAO |
Apr 02 '25 |
Sale |
15.74 |
76 |
1,196 |
42,445 |
Vitale Lucas | CP&BOO |
Mar 18 '25 |
Sale |
16.60 |
4,287 |
71,164 |
135,317 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):